0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blonanserin Tablets Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-5J18427
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Blonanserin Tablets Market Research Report 2024
BUY CHAPTERS

Global Blonanserin Tablets Market Research Report 2024

Code: QYRE-Auto-5J18427
Report
October 2024
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blonanserin Tablets Market

Blonanserin Tablets are a medication primarily used to treat schizophrenia, a mental health disorder characterized by distorted thinking, perception, emotions, and behavior. Blonanserin is classified as an atypical antipsychotic or second-generation antipsychotic and works by modulating the activity of certain neurotransmitters in the brain, such as dopamine and serotonin.
The global Blonanserin Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Blonanserin Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Blonanserin Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Blonanserin Tablets include Sumitomo Pharma, Recipharm, Intas, Shijiazhuang No.4 Pharmaceutical, LIVZON PHARMACEUTICAL, Xiangzhong Pharmaceutical, Lifecare Neuro Products, Taj Life Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blonanserin Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blonanserin Tablets.
The Blonanserin Tablets market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Blonanserin Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blonanserin Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Blonanserin Tablets Market Report

Report Metric Details
Report Name Blonanserin Tablets Market
Segment by Type
  • 4mg
  • 8mg
Segment by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sumitomo Pharma, Recipharm, Intas, Shijiazhuang No.4 Pharmaceutical, LIVZON PHARMACEUTICAL, Xiangzhong Pharmaceutical, Lifecare Neuro Products, Taj Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Blonanserin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Blonanserin Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Blonanserin Tablets Market report?

Ans: The main players in the Blonanserin Tablets Market are Sumitomo Pharma, Recipharm, Intas, Shijiazhuang No.4 Pharmaceutical, LIVZON PHARMACEUTICAL, Xiangzhong Pharmaceutical, Lifecare Neuro Products, Taj Life Sciences

What are the Application segmentation covered in the Blonanserin Tablets Market report?

Ans: The Applications covered in the Blonanserin Tablets Market report are Adults, Children

What are the Type segmentation covered in the Blonanserin Tablets Market report?

Ans: The Types covered in the Blonanserin Tablets Market report are 4mg, 8mg

1 Blonanserin Tablets Market Overview
1.1 Product Definition
1.2 Blonanserin Tablets by Type
1.2.1 Global Blonanserin Tablets Market Value Comparison by Type (2024-2030)
1.2.2 4mg
1.2.3 8mg
1.3 Blonanserin Tablets by Application
1.3.1 Global Blonanserin Tablets Market Value by Application (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Blonanserin Tablets Market Size Estimates and Forecasts
1.4.1 Global Blonanserin Tablets Revenue 2019-2030
1.4.2 Global Blonanserin Tablets Sales 2019-2030
1.4.3 Global Blonanserin Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Blonanserin Tablets Market Competition by Manufacturers
2.1 Global Blonanserin Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Blonanserin Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Blonanserin Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Blonanserin Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Blonanserin Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blonanserin Tablets, Product Type & Application
2.7 Global Key Manufacturers of Blonanserin Tablets, Date of Enter into This Industry
2.8 Global Blonanserin Tablets Market Competitive Situation and Trends
2.8.1 Global Blonanserin Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Blonanserin Tablets Players Market Share by Revenue
2.8.3 Global Blonanserin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blonanserin Tablets Market Scenario by Region
3.1 Global Blonanserin Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Blonanserin Tablets Sales by Region: 2019-2030
3.2.1 Global Blonanserin Tablets Sales by Region: 2019-2024
3.2.2 Global Blonanserin Tablets Sales by Region: 2025-2030
3.3 Global Blonanserin Tablets Revenue by Region: 2019-2030
3.3.1 Global Blonanserin Tablets Revenue by Region: 2019-2024
3.3.2 Global Blonanserin Tablets Revenue by Region: 2025-2030
3.4 North America Blonanserin Tablets Market Facts & Figures by Country
3.4.1 North America Blonanserin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Blonanserin Tablets Sales by Country (2019-2030)
3.4.3 North America Blonanserin Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Blonanserin Tablets Market Facts & Figures by Country
3.5.1 Europe Blonanserin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Blonanserin Tablets Sales by Country (2019-2030)
3.5.3 Europe Blonanserin Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blonanserin Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Blonanserin Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Blonanserin Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Blonanserin Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Blonanserin Tablets Market Facts & Figures by Country
3.7.1 Latin America Blonanserin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Blonanserin Tablets Sales by Country (2019-2030)
3.7.3 Latin America Blonanserin Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Blonanserin Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Blonanserin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Blonanserin Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Blonanserin Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Blonanserin Tablets Sales by Type (2019-2030)
4.1.1 Global Blonanserin Tablets Sales by Type (2019-2024)
4.1.2 Global Blonanserin Tablets Sales by Type (2025-2030)
4.1.3 Global Blonanserin Tablets Sales Market Share by Type (2019-2030)
4.2 Global Blonanserin Tablets Revenue by Type (2019-2030)
4.2.1 Global Blonanserin Tablets Revenue by Type (2019-2024)
4.2.2 Global Blonanserin Tablets Revenue by Type (2025-2030)
4.2.3 Global Blonanserin Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Blonanserin Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Blonanserin Tablets Sales by Application (2019-2030)
5.1.1 Global Blonanserin Tablets Sales by Application (2019-2024)
5.1.2 Global Blonanserin Tablets Sales by Application (2025-2030)
5.1.3 Global Blonanserin Tablets Sales Market Share by Application (2019-2030)
5.2 Global Blonanserin Tablets Revenue by Application (2019-2030)
5.2.1 Global Blonanserin Tablets Revenue by Application (2019-2024)
5.2.2 Global Blonanserin Tablets Revenue by Application (2025-2030)
5.2.3 Global Blonanserin Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Blonanserin Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sumitomo Pharma
6.1.1 Sumitomo Pharma Company Information
6.1.2 Sumitomo Pharma Description and Business Overview
6.1.3 Sumitomo Pharma Blonanserin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sumitomo Pharma Blonanserin Tablets Product Portfolio
6.1.5 Sumitomo Pharma Recent Developments/Updates
6.2 Recipharm
6.2.1 Recipharm Company Information
6.2.2 Recipharm Description and Business Overview
6.2.3 Recipharm Blonanserin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Recipharm Blonanserin Tablets Product Portfolio
6.2.5 Recipharm Recent Developments/Updates
6.3 Intas
6.3.1 Intas Company Information
6.3.2 Intas Description and Business Overview
6.3.3 Intas Blonanserin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Intas Blonanserin Tablets Product Portfolio
6.3.5 Intas Recent Developments/Updates
6.4 Shijiazhuang No.4 Pharmaceutical
6.4.1 Shijiazhuang No.4 Pharmaceutical Company Information
6.4.2 Shijiazhuang No.4 Pharmaceutical Description and Business Overview
6.4.3 Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Product Portfolio
6.4.5 Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
6.5 LIVZON PHARMACEUTICAL
6.5.1 LIVZON PHARMACEUTICAL Company Information
6.5.2 LIVZON PHARMACEUTICAL Description and Business Overview
6.5.3 LIVZON PHARMACEUTICAL Blonanserin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 LIVZON PHARMACEUTICAL Blonanserin Tablets Product Portfolio
6.5.5 LIVZON PHARMACEUTICAL Recent Developments/Updates
6.6 Xiangzhong Pharmaceutical
6.6.1 Xiangzhong Pharmaceutical Company Information
6.6.2 Xiangzhong Pharmaceutical Description and Business Overview
6.6.3 Xiangzhong Pharmaceutical Blonanserin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Xiangzhong Pharmaceutical Blonanserin Tablets Product Portfolio
6.6.5 Xiangzhong Pharmaceutical Recent Developments/Updates
6.7 Lifecare Neuro Products
6.7.1 Lifecare Neuro Products Company Information
6.7.2 Lifecare Neuro Products Description and Business Overview
6.7.3 Lifecare Neuro Products Blonanserin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Lifecare Neuro Products Blonanserin Tablets Product Portfolio
6.7.5 Lifecare Neuro Products Recent Developments/Updates
6.8 Taj Life Sciences
6.8.1 Taj Life Sciences Company Information
6.8.2 Taj Life Sciences Description and Business Overview
6.8.3 Taj Life Sciences Blonanserin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Taj Life Sciences Blonanserin Tablets Product Portfolio
6.8.5 Taj Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blonanserin Tablets Industry Chain Analysis
7.2 Blonanserin Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blonanserin Tablets Production Mode & Process
7.4 Blonanserin Tablets Sales and Marketing
7.4.1 Blonanserin Tablets Sales Channels
7.4.2 Blonanserin Tablets Distributors
7.5 Blonanserin Tablets Customers
8 Blonanserin Tablets Market Dynamics
8.1 Blonanserin Tablets Industry Trends
8.2 Blonanserin Tablets Market Drivers
8.3 Blonanserin Tablets Market Challenges
8.4 Blonanserin Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Blonanserin Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Blonanserin Tablets Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Blonanserin Tablets Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Blonanserin Tablets Sales (kg) of Key Manufacturers (2019-2024)
 Table 5. Global Blonanserin Tablets Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Blonanserin Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Blonanserin Tablets Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Blonanserin Tablets Average Price (US$/g) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Blonanserin Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Blonanserin Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Blonanserin Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Blonanserin Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Blonanserin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blonanserin Tablets as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Blonanserin Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Blonanserin Tablets Sales by Region (2019-2024) & (kg)
 Table 18. Global Blonanserin Tablets Sales Market Share by Region (2019-2024)
 Table 19. Global Blonanserin Tablets Sales by Region (2025-2030) & (kg)
 Table 20. Global Blonanserin Tablets Sales Market Share by Region (2025-2030)
 Table 21. Global Blonanserin Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Blonanserin Tablets Revenue Market Share by Region (2019-2024)
 Table 23. Global Blonanserin Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Blonanserin Tablets Revenue Market Share by Region (2025-2030)
 Table 25. North America Blonanserin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Blonanserin Tablets Sales by Country (2019-2024) & (kg)
 Table 27. North America Blonanserin Tablets Sales by Country (2025-2030) & (kg)
 Table 28. North America Blonanserin Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Blonanserin Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Blonanserin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Blonanserin Tablets Sales by Country (2019-2024) & (kg)
 Table 32. Europe Blonanserin Tablets Sales by Country (2025-2030) & (kg)
 Table 33. Europe Blonanserin Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Blonanserin Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Blonanserin Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Blonanserin Tablets Sales by Region (2019-2024) & (kg)
 Table 37. Asia Pacific Blonanserin Tablets Sales by Region (2025-2030) & (kg)
 Table 38. Asia Pacific Blonanserin Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Blonanserin Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Blonanserin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Blonanserin Tablets Sales by Country (2019-2024) & (kg)
 Table 42. Latin America Blonanserin Tablets Sales by Country (2025-2030) & (kg)
 Table 43. Latin America Blonanserin Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Blonanserin Tablets Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Blonanserin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Blonanserin Tablets Sales by Country (2019-2024) & (kg)
 Table 47. Middle East and Africa Blonanserin Tablets Sales by Country (2025-2030) & (kg)
 Table 48. Middle East and Africa Blonanserin Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Blonanserin Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Blonanserin Tablets Sales (kg) by Type (2019-2024)
 Table 51. Global Blonanserin Tablets Sales (kg) by Type (2025-2030)
 Table 52. Global Blonanserin Tablets Sales Market Share by Type (2019-2024)
 Table 53. Global Blonanserin Tablets Sales Market Share by Type (2025-2030)
 Table 54. Global Blonanserin Tablets Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Blonanserin Tablets Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Blonanserin Tablets Revenue Market Share by Type (2019-2024)
 Table 57. Global Blonanserin Tablets Revenue Market Share by Type (2025-2030)
 Table 58. Global Blonanserin Tablets Price (US$/g) by Type (2019-2024)
 Table 59. Global Blonanserin Tablets Price (US$/g) by Type (2025-2030)
 Table 60. Global Blonanserin Tablets Sales (kg) by Application (2019-2024)
 Table 61. Global Blonanserin Tablets Sales (kg) by Application (2025-2030)
 Table 62. Global Blonanserin Tablets Sales Market Share by Application (2019-2024)
 Table 63. Global Blonanserin Tablets Sales Market Share by Application (2025-2030)
 Table 64. Global Blonanserin Tablets Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Blonanserin Tablets Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Blonanserin Tablets Revenue Market Share by Application (2019-2024)
 Table 67. Global Blonanserin Tablets Revenue Market Share by Application (2025-2030)
 Table 68. Global Blonanserin Tablets Price (US$/g) by Application (2019-2024)
 Table 69. Global Blonanserin Tablets Price (US$/g) by Application (2025-2030)
 Table 70. Sumitomo Pharma Company Information
 Table 71. Sumitomo Pharma Description and Business Overview
 Table 72. Sumitomo Pharma Blonanserin Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 73. Sumitomo Pharma Blonanserin Tablets Product
 Table 74. Sumitomo Pharma Recent Developments/Updates
 Table 75. Recipharm Company Information
 Table 76. Recipharm Description and Business Overview
 Table 77. Recipharm Blonanserin Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 78. Recipharm Blonanserin Tablets Product
 Table 79. Recipharm Recent Developments/Updates
 Table 80. Intas Company Information
 Table 81. Intas Description and Business Overview
 Table 82. Intas Blonanserin Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 83. Intas Blonanserin Tablets Product
 Table 84. Intas Recent Developments/Updates
 Table 85. Shijiazhuang No.4 Pharmaceutical Company Information
 Table 86. Shijiazhuang No.4 Pharmaceutical Description and Business Overview
 Table 87. Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 88. Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Product
 Table 89. Shijiazhuang No.4 Pharmaceutical Recent Developments/Updates
 Table 90. LIVZON PHARMACEUTICAL Company Information
 Table 91. LIVZON PHARMACEUTICAL Description and Business Overview
 Table 92. LIVZON PHARMACEUTICAL Blonanserin Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 93. LIVZON PHARMACEUTICAL Blonanserin Tablets Product
 Table 94. LIVZON PHARMACEUTICAL Recent Developments/Updates
 Table 95. Xiangzhong Pharmaceutical Company Information
 Table 96. Xiangzhong Pharmaceutical Description and Business Overview
 Table 97. Xiangzhong Pharmaceutical Blonanserin Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 98. Xiangzhong Pharmaceutical Blonanserin Tablets Product
 Table 99. Xiangzhong Pharmaceutical Recent Developments/Updates
 Table 100. Lifecare Neuro Products Company Information
 Table 101. Lifecare Neuro Products Description and Business Overview
 Table 102. Lifecare Neuro Products Blonanserin Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 103. Lifecare Neuro Products Blonanserin Tablets Product
 Table 104. Lifecare Neuro Products Recent Developments/Updates
 Table 105. Taj Life Sciences Company Information
 Table 106. Taj Life Sciences Description and Business Overview
 Table 107. Taj Life Sciences Blonanserin Tablets Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 108. Taj Life Sciences Blonanserin Tablets Product
 Table 109. Taj Life Sciences Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Blonanserin Tablets Distributors List
 Table 113. Blonanserin Tablets Customers List
 Table 114. Blonanserin Tablets Market Trends
 Table 115. Blonanserin Tablets Market Drivers
 Table 116. Blonanserin Tablets Market Challenges
 Table 117. Blonanserin Tablets Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Blonanserin Tablets
 Figure 2. Global Blonanserin Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Blonanserin Tablets Market Share by Type: 2023 & 2030
 Figure 4. 4mg Product Picture
 Figure 5. 8mg Product Picture
 Figure 6. Global Blonanserin Tablets Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Blonanserin Tablets Market Share by Application: 2023 & 2030
 Figure 8. Adults
 Figure 9. Children
 Figure 10. Global Blonanserin Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Blonanserin Tablets Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Blonanserin Tablets Sales (2019-2030) & (kg)
 Figure 13. Global Blonanserin Tablets Average Price (US$/g) & (2019-2030)
 Figure 14. Blonanserin Tablets Report Years Considered
 Figure 15. Blonanserin Tablets Sales Share by Manufacturers in 2023
 Figure 16. Global Blonanserin Tablets Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Blonanserin Tablets Players: Market Share by Revenue in Blonanserin Tablets in 2023
 Figure 18. Blonanserin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Blonanserin Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Blonanserin Tablets Sales Market Share by Country (2019-2030)
 Figure 21. North America Blonanserin Tablets Revenue Market Share by Country (2019-2030)
 Figure 22. United States Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Blonanserin Tablets Sales Market Share by Country (2019-2030)
 Figure 25. Europe Blonanserin Tablets Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Blonanserin Tablets Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Blonanserin Tablets Revenue Market Share by Region (2019-2030)
 Figure 33. China Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Blonanserin Tablets Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Blonanserin Tablets Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Blonanserin Tablets Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Blonanserin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Blonanserin Tablets by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Blonanserin Tablets by Type (2019-2030)
 Figure 52. Global Blonanserin Tablets Price (US$/g) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Blonanserin Tablets by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Blonanserin Tablets by Application (2019-2030)
 Figure 55. Global Blonanserin Tablets Price (US$/g) by Application (2019-2030)
 Figure 56. Blonanserin Tablets Value Chain
 Figure 57. Blonanserin Tablets Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS